C3O_C8OC26~)L~[1E_QB?,Z,|YYFA|VB%W
SYSTEM PROCESSING...
C3O_C8OC26~)L~[1E_QB?,Z,|YYFA|VB%W
SYSTEM PROCESSING...
Posted: 2025-06-26 12:11:28 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-06-26 12:19:48 UTC
Verified By
Rollup News
Two new Nordic studies have found that Ozempic, a widely prescribed diabetes drug, may double the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition that can lead to sudden vision loss.
Ozempic doubles the risk of NAION, a condition causing sudden vision loss.
NAION is considered the most common cause of sudden vision loss in people over 50.
Cases of NAION have increased since Ozempic was introduced in 2018.
Researchers caution against immediate cessation of Ozempic treatment.
Increased risk of NAION with Ozempic use.
Potential for severe and permanent vision loss.
Uncertainty about whether the risk is specific to semaglutide or a class effect.